Kidney International Reports (Mar 2022)
Compassionate Use of Avacopan in Difficult-to-Treat Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
- Jolijn R. van Leeuwen,
- Obbo W. Bredewold,
- Laura S. van Dam,
- Stella L. Werkman,
- Jacqueline T. Jonker,
- Miranda Geelhoed,
- Antonius P.M. Langeveld,
- Hilde H.F. Remmelts,
- Maud M. van den Broecke,
- Argho Ray,
- Ton J. Rabelink,
- Y.K. Onno Teng
Affiliations
- Jolijn R. van Leeuwen
- Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine—Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands
- Obbo W. Bredewold
- Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine—Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands
- Laura S. van Dam
- Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine—Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands
- Stella L. Werkman
- Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine—Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands
- Jacqueline T. Jonker
- Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine—Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands; Department of Nephrology, Alrijne Ziekenhuis, Leiden, The Netherlands
- Miranda Geelhoed
- Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands
- Antonius P.M. Langeveld
- Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department Otorhinolaryngology, Leiden University Medical Center, Leiden, The Netherlands
- Hilde H.F. Remmelts
- Department of Nephrology, Meander Medisch Centrum, Amersfoort, The Netherlands
- Maud M. van den Broecke
- Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine—Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands
- Argho Ray
- Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine—Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands
- Ton J. Rabelink
- Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine—Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands
- Y.K. Onno Teng
- Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine—Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands; Correspondence: Y.K. Onno Teng, Department of Nephrology, Leiden University Medical Center (LUMC), P.O. Box 9600, 2300 RC Leiden, The Netherlands.
- Journal volume & issue
-
Vol. 7,
no. 3
pp. 624 – 628